Showing results (281-290 of 1,563) with videos related to
Sort By:
Pageof 157
The Journal of Antimicrobial Chemotherapy|October 26, 2020
Efficacy of human-simulated exposures of meropenem/vaborbactam and meropenem against OXA-48 β-lactamase-producing Enterobacterales in the neutropenic murine thigh infection modelChristian M Gill, Tomefa E Asempa, David P NicolauAntibiotics (Basel, Switzerland)|October 30, 2020
Development and Application of a Pragmatic Algorithm to Guide Definitive Carbapenemase Testing to Identify Carbapenemase-Producing Pseudomonas aeruginosaChristian M Gill, Tomefa E Asempa, David P NicolauHuman Pathology|March 22, 2016
Expression of liver fatty acid binding protein in hepatocellular carcinomaSoo-Jin Cho, Linda D Ferrell, Ryan M GillJournal of General Internal Medicine|January 22, 1998
Predictors of recovery in activities of daily living among disabled older persons living in the communityT M Gill, J T Robison, M E TinettiPacing and Clinical Electrophysiology : PACE|April 1, 1993
The defibrillation threshold: a comparison of anesthetics and measurement methodsR M Gill, R J Sweeney, P R ReidJAMA Network Open|January 3, 2025
Exposure to School Racial Segregation and Late-Life Cognitive OutcomesZhuoer Lin, Yi Wang, Thomas M Gill, et al.ASM Case Reports|November 17, 2025
Cefepime failure for the treatment of cefepime-susceptible, KPC-producing Escherichia coli emphysematous cystitisJordynne Morelan, Rong Hou, Robin Chamberland, et al.The Journal of Antimicrobial Chemotherapy|October 15, 2023
Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosaSu Young Lee, Christian M Gill, David P Nicolau, et al.Archives of Internal Medicine|August 3, 2002
Should we screen for hemochromatosis? An examination of evidence of downstream effects on morbidity and mortalityArch G Mainous, James M Gill, William S PearsonThe Journal of Laboratory and Clinical Medicine|February 1, 1982
Abnormal red cell membrane proteolytic activity in severe heterozygous beta-thalassemiaS K Ballas, E R Burka, F M GillPageof 157